发明名称 PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide advantageous characteristics of overcoming conventional faults or at least reducing them, and avoiding frequent administration of an effective medicament (for example one dose per day), and to provide a sustained release preparation of a soluble medicament achieving the blood concentration achieved by frequently administering a small dose of the medicament (two or more doses per day), e.g. 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-dibenzo[b,f][1,4]thiazepine or a pharmaceutically acceptable salt thereof. SOLUTION: The sustained release preparation contains hydroxypropylmethylcellulose and the 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-dibenzo[b,f][1,4]thiazepine or the pharmaceutically acceptable salt thereof with one or more kinds of pharmaceutically acceptable vehicles. COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP2006152006(A) 申请公布日期 2006.06.15
申请号 JP20060071695 申请日期 2006.03.15
申请人 ASTRAZENECA UK LTD 发明人 PARIKH BHAVNISH VINOD;TIMKO ROBERT JOSEPH;ADDICKS WILLIAM JOSEPH
分类号 A61K31/496;A61K47/38;A61K9/08;A61K9/20;A61K9/22;A61K9/51;A61K31/55;A61K31/554;A61K47/12;A61K47/26;A61K47/32;A61P25/18 主分类号 A61K31/496
代理机构 代理人
主权项
地址